SKYE compared with TRDA: revenue, margins and what each company keeps, and the suppliers and customers both name

SKYESkye Bioscience, Inc.

Mkt capRevenueRevenue

TRDAEntrada Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SKYESkye Bioscience, Inc.

TRDAEntrada Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SKYE 1

HALOHalozymesupplier

Shared 0

No shared counterparties.

Only TRDA 3

VRTXVertex Pharmaceuticalscustomer

—Ohio State Innovation Foundationunlistedsupplier

—Pierrepont Therapeuticsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

SKYESkye Bioscience, Inc.

1.34▲+1.50%· post 1.25

Mkt cap$5.8MRevenue—Revenue—

TRDAEntrada Therapeutics, Inc.

4.72▼−7.73%· post 4.80

ClosedNov 3 '26

Mkt cap$183.8MRevenue$898,000Q2 FY26Revenue$25MFY25

Compare

ClosedNov 3 '26

SKYESkye Bioscience, Inc.

TRDAEntrada Therapeutics, Inc.

1.34▲+1.50%post 1.25

Price

4.72▼−7.73%post 4.80

$5.8M

Mkt cap

$183.8M

—

Revenue

$898,000Q2 FY26

—

Revenue

$25MFY25

SKYE1.34▲+1.50%vsTRDA4.72▼−7.73%ClosedNov 3 '26